48 related articles for article (PubMed ID: 30046315)
1. Pericytes Are Immunoregulatory Cells in Glioma Genesis and Progression.
Martinez-Morga M; Garrigos D; Rodriguez-Montero E; Pombero A; Garcia-Lopez R; Martinez S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791110
[TBL] [Abstract][Full Text] [Related]
2. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura PP; Quintela NV; García MM; Del Barco Berrón S; Sarrió RG; Gómez JG; Castaño AG; Martín LMN; Rubio OG; Losada EP
Clin Transl Oncol; 2023 Sep; 25(9):2634-2646. PubMed ID: 37540408
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial.
Brazil L; Swampillai AL; Mak KM; Edwards D; Mesiri P; Clifton-Hadley L; Shaffer R; Lewis J; Watts C; Jeffries S; Gkogkou P; Chalmers AJ; Fersht NL; Hackshaw A; Short SC
Neurooncol Adv; 2020; 2(1):vdaa046. PubMed ID: 32642699
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Wen PY; Weller M; Lee EQ; Alexander BM; Barnholtz-Sloan JS; Barthel FP; Batchelor TT; Bindra RS; Chang SM; Chiocca EA; Cloughesy TF; DeGroot JF; Galanis E; Gilbert MR; Hegi ME; Horbinski C; Huang RY; Lassman AB; Le Rhun E; Lim M; Mehta MP; Mellinghoff IK; Minniti G; Nathanson D; Platten M; Preusser M; Roth P; Sanson M; Schiff D; Short SC; Taphoorn MJB; Tonn JC; Tsang J; Verhaak RGW; von Deimling A; Wick W; Zadeh G; Reardon DA; Aldape KD; van den Bent MJ
Neuro Oncol; 2020 Aug; 22(8):1073-1113. PubMed ID: 32328653
[TBL] [Abstract][Full Text] [Related]
5. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
Kranjc MK; Novak M; Pestell RG; Lah TT
Radiol Oncol; 2019 Nov; 53(4):397-406. PubMed ID: 31747383
[TBL] [Abstract][Full Text] [Related]
6. Risks to Health and Well-Being From Radio-Frequency Radiation Emitted by Cell Phones and Other Wireless Devices.
Miller AB; Sears ME; Morgan LL; Davis DL; Hardell L; Oremus M; Soskolne CL
Front Public Health; 2019; 7():223. PubMed ID: 31457001
[TBL] [Abstract][Full Text] [Related]
7. [GLIOBLASTOMA MULTIFORME--THE PROGRESS OF KNOWLEDGE ON THE PATHOGENESIS OF CANCER].
Wańkowicz P; Nowacki P
Ann Acad Med Stetin; 2014; 60(2):40-3. PubMed ID: 26591106
[TBL] [Abstract][Full Text] [Related]
8. Authors' Comment on "Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor".
Philips A; Henshaw DL; Lamburn G; O'Carroll MJ
J Environ Public Health; 2018; 2018():2170208. PubMed ID: 30046315
[No Abstract] [Full Text] [Related]
9. Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015.
Davis FG; Smith TR; Gittleman HR; Ostrom QT; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2020 Feb; 22(2):301-302. PubMed ID: 31786602
[No Abstract] [Full Text] [Related]
10. Analyses of temporal and spatial patterns of glioblastoma multiforme and other brain cancer subtypes in relation to mobile phones using synthetic counterfactuals.
de Vocht F
Environ Res; 2019 Jan; 168():329-335. PubMed ID: 30384227
[TBL] [Abstract][Full Text] [Related]
11. Integrative tumor board: glioblastoma multiforme.
Dixit S; Pueschel JK; Wallace JM; Bolletino RC; Block KI
Integr Cancer Ther; 2004 Jun; 3(2):149-72. PubMed ID: 15165500
[No Abstract] [Full Text] [Related]
12. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients.
Pompili A; Telera S; Villani V; Pace A
Neurosurg Focus; 2014 Dec; 37(6):E5. PubMed ID: 25434390
[TBL] [Abstract][Full Text] [Related]
13. Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor.
Philips A; Henshaw DL; Lamburn G; O'Carroll MJ
J Environ Public Health; 2018; 2018():7910754. PubMed ID: 30034480
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
